Chemical tools to monitor bladder cancer progression.


Journal

Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals
ISSN: 1366-5804
Titre abrégé: Biomarkers
Pays: England
ID NLM: 9606000

Informations de publication

Date de publication:
Sep 2022
Historique:
pubmed: 10 5 2022
medline: 9 9 2022
entrez: 9 5 2022
Statut: ppublish

Résumé

Bladder cancer (BCa) is the most common cancer of the urinary system. Due to its high incidence and recurrence, as well as limited progress in the effective treatment, BCa is a challenge for today's medicine. We used a set of chromogenic substrates to differentiate between the stages of bladder cancer progression (G1 ( The specific activity of enzymes in the urine of patients with confirmed bladder cancer was determined separately for three (G1, G2, G3) stages of the disease development. What is more, no activity was observed in urine of healthy people ( Research shows that specific enzymes are associated with the development of specific stages of cancer. We suspect that the differences in the proteolytic activity of urine samples are due to the presence of a different set of enzymes that are directly related to the particular stage of the disease. We obtained three substrates for monitoring individual stages of bladder cancer development.

Sections du résumé

BACKGROUND UNASSIGNED
Bladder cancer (BCa) is the most common cancer of the urinary system. Due to its high incidence and recurrence, as well as limited progress in the effective treatment, BCa is a challenge for today's medicine.
MATERIALS AND METHODS UNASSIGNED
We used a set of chromogenic substrates to differentiate between the stages of bladder cancer progression (G1 (
RESULTS UNASSIGNED
The specific activity of enzymes in the urine of patients with confirmed bladder cancer was determined separately for three (G1, G2, G3) stages of the disease development. What is more, no activity was observed in urine of healthy people (
DISCUSSION UNASSIGNED
Research shows that specific enzymes are associated with the development of specific stages of cancer. We suspect that the differences in the proteolytic activity of urine samples are due to the presence of a different set of enzymes that are directly related to the particular stage of the disease.
CONCLUSION UNASSIGNED
We obtained three substrates for monitoring individual stages of bladder cancer development.

Identifiants

pubmed: 35532038
doi: 10.1080/1354750X.2022.2076153
doi:

Substances chimiques

Biomarkers, Tumor 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

568-578

Auteurs

Natalia Gruba (N)

Faculty of Chemistry, University of Gdansk, Gdańsk, Poland.

Lech Stachurski (L)

Urology Department, City Hospital, Edinburgh, United Kingdom of Great Britain and Northern Ireland.

Adam Lesner (A)

Faculty of Chemistry, University of Gdansk, Gdańsk, Poland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH